Bacteriocin TP

General Information


DRACP ID  DRACP00670

Peptide Name   Bacteriocin TP

Sequence  ASVVNKLTGGVAGLLK

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Bacillus subtilis

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MKN 45 Gastric adenocarcinoma Carcinoma IC50=4.686µM MTT assay 48h 1
NB4 Acute promyelocytic leukemia with PML-RARA ; Acute promyelocytic leukemia Leukemia IC50=11.479µM MTT assay 48h 1

Hemolytic Activity  Mouse erythrocytes: <10% Hemolysis=160µM; 10% Hemolysis=320µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00670

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C68H123N19O20

Absent amino acids  CDEFHIMPQRWY

Common amino acids  GLV

Mass  179459

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  8

Net charge  2

Boman Index  961

Hydrophobicity  85

Aliphatic Index  140

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28254375

Title  Isolation and characterisation of a novel antibacterial peptide from a native swine intestinal tract-derived bacterium

Doi 10.1016/j.ijantimicag.2016.12.012

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.